Period of time： 2013年5期
Publisher： Future Medicine
Founded in： 2012
Total resources： 6
ISSN： 2045-0907
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
CNS Oncology,volume 2,issue 5
Menu
Oncolytic virotherapy for gliomas: steps toward the future
By Kaufmann Johanna K,Chiocca E Antonio in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.
Access to resources
Recommend
By Shim Hyunsuk,Holder Chad A,Olson Jeffrey J in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.By Massimino Maura,Junck Larry in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Conference Scene: Neuro-oncology: a selected review of ASCO 2013 abstracts
By Chamberlain Marc C in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Bevacizumab for acute neurologic deterioration in patients with glioblastoma
By Kaley Thomas,Nolan Craig,Carver Alan,Omuro Antonio in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.What is the most appropriate clinical target volume for glioblastoma?
By Lo Simon S,Sahgal Arjun,Slotman Ben J,Mansur David B,Khouri Anton,Sloan Andrew E,Machtay Mitchell,Chang Eric L in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.Novel therapeutic delivery approaches in development for pediatric gliomas
By Warren Katherine E in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.By Anwar Mekhail,Barani Igor J in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.By Walker David,Hamilton Willie,Walter Fiona M,Watts Colin in (2013)
CNS Oncology,volume 2,issue 5 , Vol. 2, Iss. 5, 2013-09 , pp.
Previous
Next